ADMA Biologics Inc (ADMA)
19.38
-0.06
(-0.28%)
USD |
NASDAQ |
Sep 27, 16:00
19.38
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics SG&A Expense (TTM): 62.51M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 62.51M |
March 31, 2024 | 60.15M |
December 31, 2023 | 59.02M |
September 30, 2023 | 57.38M |
June 30, 2023 | 55.55M |
March 31, 2023 | 53.27M |
December 31, 2022 | 52.46M |
September 30, 2022 | 50.26M |
June 30, 2022 | 48.09M |
March 31, 2022 | 46.56M |
December 31, 2021 | 42.90M |
September 30, 2021 | 40.50M |
June 30, 2021 | 38.89M |
March 31, 2021 | 37.15M |
December 31, 2020 | 35.05M |
September 30, 2020 | 32.78M |
June 30, 2020 | 30.86M |
March 31, 2020 | 28.25M |
December 31, 2019 | 25.91M |
September 30, 2019 | 24.95M |
June 30, 2019 | 23.42M |
March 31, 2019 | 22.78M |
December 31, 2018 | 22.50M |
September 30, 2018 | 22.27M |
June 30, 2018 | 20.80M |
Date | Value |
---|---|
March 31, 2018 | 19.80M |
December 31, 2017 | 18.75M |
September 30, 2017 | 16.19M |
June 30, 2017 | 13.78M |
March 31, 2017 | 11.06M |
December 31, 2016 | 8.495M |
September 30, 2016 | 7.096M |
June 30, 2016 | 7.395M |
March 31, 2016 | 7.108M |
December 31, 2015 | 6.746M |
September 30, 2015 | 5.974M |
June 30, 2015 | 4.931M |
March 31, 2015 | 5.035M |
December 31, 2014 | 4.824M |
September 30, 2014 | 4.710M |
June 30, 2014 | 4.521M |
March 31, 2014 | 4.069M |
December 31, 2013 | 4.365M |
September 30, 2013 | 4.063M |
June 30, 2013 | 4.252M |
March 31, 2013 | 3.899M |
December 31, 2012 | 3.142M |
September 30, 2012 | 2.450M |
June 30, 2012 | 1.419M |
March 31, 2012 | 0.6972M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
24.95M
Minimum
Sep 2019
62.51M
Maximum
Jun 2024
44.12M
Average
44.73M
Median
SG&A Expense (TTM) Benchmarks
Pfizer Inc | 15.07B |
TG Therapeutics Inc | 137.29M |
Varex Imaging Corp | 135.40M |
Krystal Biotech Inc | 102.14M |
Bioventus Inc | 321.37M |